Davis PB - Search Results

1

Neuromonics Tinnitus Treatment: third clinical trial.

Davis PB, Paki B, Hanley PJ. Davis PB, et al. Ear Hear. 2007 Apr;28(2):242-59. doi: 10.1097/AUD.0b013e3180312619. Ear Hear. 2007. PMID: 17496674 Clinical Trial.

2

Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: clinical outcomes in general private practice.

Hanley PJ, Davis PB, Paki B, Quinn SA, Bellekom SR. Hanley PJ, et al. Among authors: davis pb. Ann Otol Rhinol Laryngol. 2008 Nov;117(11):791-9. doi: 10.1177/000348940811701101. Ann Otol Rhinol Laryngol. 2008. PMID: 19102123 Clinical Trial.

3

Treatment of tinnitus with a customized, dynamic acoustic neural stimulus: underlying principles and clinical efficacy.

Hanley PJ, Davis PB. Hanley PJ, et al. Among authors: davis pb. Trends Amplif. 2008 Sep;12(3):210-22. doi: 10.1177/1084713808319942. Epub 2008 Jul 9. Trends Amplif. 2008. PMID: 18614554 Free PMC article.

4

Treatment of tinnitus with a customized acoustic neural stimulus: a controlled clinical study.

Davis PB, Wilde RA, Steed LG, Hanley PJ. Davis PB, et al. Ear Nose Throat J. 2008 Jun;87(6):330-9. Ear Nose Throat J. 2008. PMID: 18561116 Clinical Trial.

5

COVID-19 and dementia: Analyses of risk, disparity, and outcomes from electronic health records in the US.

Wang Q, Davis PB, Gurney ME, Xu R. Wang Q, et al. Among authors: davis pb. Alzheimers Dement. 2021 Feb 9. doi: 10.1002/alz.12296. Online ahead of print. Alzheimers Dement. 2021. PMID: 33559975

6

COVID-19 risk, disparities and outcomes in patients with chronic liver disease in the United States.

Wang Q, Davis PB, Xu R. Wang Q, et al. Among authors: davis pb. EClinicalMedicine. 2021 Jan;31:100688. doi: 10.1016/j.eclinm.2020.100688. Epub 2020 Dec 22. EClinicalMedicine. 2021. PMID: 33521611 Free PMC article.

7

Transitions to and from long-term care facilities and length of completed stay: Reuse of population-based survey data.

Broad JB, Lumley T, Ashton T, Davis PB, Boyd M, Connolly MJ. Broad JB, et al. Among authors: davis pb. Australas J Ageing. 2017 Jun;36(2):E1-E7. doi: 10.1111/ajag.12378. Epub 2017 Mar 20. Australas J Ageing. 2017. PMID: 28319325

8

Epidemiology of Cystic Fibrosis.

Spoonhower KA, Davis PB. Spoonhower KA, et al. Among authors: davis pb. Clin Chest Med. 2016 Mar;37(1):1-8. doi: 10.1016/j.ccm.2015.10.002. Clin Chest Med. 2016. PMID: 26857763 Review.

9

The impact on health outcome measures of switching to generic medicines consequent to reference pricing: the case of olanzapine in New Zealand.

Lessing C, Ashton T, Davis PB. Lessing C, et al. Among authors: davis pb. J Prim Health Care. 2015 Jun 1;7(2):94-101. J Prim Health Care. 2015. PMID: 26125054

10

Likelihood of residential aged care use in later life: a simple approach to estimation with international comparison.

Broad JB, Ashton T, Gott M, McLeod H, Davis PB, Connolly MJ. Broad JB, et al. Among authors: davis pb. Aust N Z J Public Health. 2015 Aug;39(4):374-9. doi: 10.1111/1753-6405.12374. Epub 2015 Jun 11. Aust N Z J Public Health. 2015. PMID: 26095070

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results